Nano Cures Raises $90M in Pre IPO Funding

15 Mar, 2021

Nano Cures Raises $90M in Pre IPO Funding
Photo by Macau Photo Agency on Unsplash

– Nano Cures Inc., an Austin, Texas-based clinical stage biotechnology and infectious disease immunity platform company, raised $90M pre-IPO funding round.
– The investment will be led by a $20M commitment from Opulence Capital Management, a Dubai based private investment fund, with existing and new investors participating.
– The company intends to use the funds to accelerate the global scale up of its Cures Platform for Covid-19 variants, including vaccines and persistent immunity delivery.

Biotechnology North America
Crunchbase icon

Content report

The following text will be sent to our editors: